Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway.
about
When 1+1>2: Nanostructured composites for hard tissue engineering applicationsPolymeric Nanostructures for Imaging and TherapyA multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells.Nano-polypharmacy to treat tumors: coencapsulation of drug combinations using nanoparticle technology.Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle.A Micro/Nano Composite for Combination Treatment of Melanoma Lung MetastasisEfficient antitumor effect of co-drug-loaded nanoparticles with gelatin hydrogel by local implantationCo-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.Cancer stem cells and personalized cancer nanomedicine.Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells.Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook.Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer.
P2860
Q30368848-1E679FC4-E02B-4033-8151-EE51E97E341EQ30372383-4C015ECC-0192-4033-8168-8A474B7504D7Q33728332-ABB01DC2-3879-40AD-85D0-B7799481FA78Q33870663-64F53A79-D2E6-4DF1-9C32-C7362C9D9A0FQ36219160-4920AEBF-4353-4FB5-9C2D-F643333806EFQ36813889-DA71CF94-0394-4EEA-832F-2857A725ACEDQ36937387-C84FD758-83F2-4362-9532-57EAA463768FQ37119643-D5DCF6B1-62B9-4359-89B3-E5FEE094816AQ38702970-EF87F78D-C99A-4CD0-AAD7-2A85D46F0D2BQ38768444-44682352-A6AA-44C2-814D-057E61294636Q38854876-59E7204E-C7F0-4723-8DA9-0B8BA58ABED3Q47760026-D4324933-B384-432D-98F9-399928A3273AQ54300242-8CD2CCC3-E981-4574-AD6A-76EAE74DB395
P2860
Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Colocalized delivery of rapamy ...... of the PI3K/Akt/mTOR pathway.
@ast
Colocalized delivery of rapamy ...... of the PI3K/Akt/mTOR pathway.
@en
type
label
Colocalized delivery of rapamy ...... of the PI3K/Akt/mTOR pathway.
@ast
Colocalized delivery of rapamy ...... of the PI3K/Akt/mTOR pathway.
@en
prefLabel
Colocalized delivery of rapamy ...... of the PI3K/Akt/mTOR pathway.
@ast
Colocalized delivery of rapamy ...... of the PI3K/Akt/mTOR pathway.
@en
P2093
P2860
P356
P1433
P1476
Colocalized delivery of rapamy ...... of the PI3K/Akt/mTOR pathway.
@en
P2093
Angela Hsiao
Argun Akcakanat
Carlos A Gonzalez-Delgado
Elvin Blanco
Francisca E Cara
Guillermo U Ruiz-Esparza
Kim-Anh Do
Kurt W Evans
Mauro Ferrari
Sergio Granados-Principal
P2860
P304
P356
10.1038/MT.2014.27
P577
2014-02-26T00:00:00Z